National Stage Applications Upon PCT/US2015/056635 Are Currently in the Process of Being Filed in Australia, Brazil, Canada, China, Colombia, Europe, Eurasia, India, Israel, Japan, Mexico, New Zealand, the Philippines, South Africa, and South Korea
DENVER, CO / ACCESSWIRE / April 20, 2017 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis"), the creator of Prana Bio Nutrient Medicinals, today announced that it is expanding protection of its intellectual properties, and National Stage applications based upon PCT/US2015/056635, and pursuant to the Patent Cooperation Treaty (PCT), for "Cannabis Extracts and Methods of Preparing and Using Same" are currently in the process of being filed in Australia, Brazil, Canada, China, Colombia, Europe, Eurasia, India, Israel, Japan, Mexico, New Zealand, the Philippines, South Africa and South Korea.
The processes included in the filing are integral to the Company's branded products, including the Prana Bio Nutrient Medicinals line, and comprise the application of strain specific ratio based phytocannabinoids, cannabinoids, chemical-free extractions, and the use of cannabis derived terpenes in the medical and pharmaceutical delivery methods, including capsules, sublinguals, topicals, transdermal applications, supplements, edibles, aerosol sprays, nebulizers, inhalers, aromatherapy, suppositories, and vaporization.
Tony Verzura, United Cannabis' Chief Technology Officer, commented on the filing, "We have always taken a scientific approach to medical cannabis, with the objective of providing patients with the highest quality product. This philosophy touches every aspect of our operation - from the genetics we use to acceptable cultivation practices, to the extraction techniques, delivery mechanisms and formulations we create - as we seek to maximize the bioavailability of each of our product profiles. As we broaden our presence in the market, it is critical that we protect the proprietary nature of our intellectual property, as well as the anticipated financial returns on our investment."
Mr. Verzura went on to say, "These filings will expand the existing international protection of our proprietary processes as well as secure the safe licensing of these technologies to interested parties around the world. I expect that we will file for additional patents branching off from this foundation as regulation develops in other countries around the world."
PCT is an international treaty that provides patent protection simultaneously in more than 145 Contracting States through a single application, rather than filing separate national or regional patent applications. The acceptance of the application by PCT establishes a filing date in all contracting states, providing the Company with a precedent against any future competing filings.
About United Cannabis Corporation
United Cannabis Corporation is a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company is a pioneer in the application of cannabinoids for medical applications and is building a platform for designing targeted therapies to increase the quality of life for patients around the world. The Company's products are patent protected, first in class medicines with applications to a global market. United Cannabis trades on the OTCQB under the symbol CNAB.
For further information, please visit www.unitedcannabis.us.
Contact: [email protected]
Phone: 303-386-7321
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
SOURCE: United Cannabis Corporation